english.prescrire.org > Prescrire International > N°263 - October 2024

n°263

October 2024

Issue Contents
Editorial

Free  DSM: still riddled with conflicts of interest

p.227

Marketing Authorisations


Finerenone (Kerendia°) in chronic kidney disease with albuminuria associated with type 2 diabetes

p.229-232

Lipegfilgrastim (Lonquex°) in the prevention of chemotherapy-induced neutropenia from 2 years of age

p.232-233

Durvalumab (Imfinzi°) in the first-line treatment of certain biliary tract cancers

p.233-234

Durvalumab (Imfinzi°) + tremelimumab (Imjudo°) as first-line treatment for certain advanced hepatocellular carcinomas

p.234-235

Durvalumab (Imfinzi°) + tremelimumab (Imjudo°) + a platinum compound as first-line treatment for certain metastatic lung cancers

p.235-236

Fenfluramine (Fintepla°) in Lennox-Gastaut syndrome

p.237-238

Solifenacin + tamsulosin (Vecalmys°) in benign prostatic hyperplasia

p.238-239

Editors' opinion. Absurd!

p.239

Nivolumab (Opdivo°) as neoadjuvant treatment in certain lung cancers at high risk of recurrence

p.240-241

Queries and comments. Which beta blocker should be used to prevent rupture of oesophageal varices?

p.241-242

Adverse Effects


Carbamazepine and pregnancy: malformations and neurodevelopmental disorders (continued)

p.243-244

Short-term interruption of treatment with a xaban or dabigatran: sometimes fatal thrombosis

p.244

Antidepressants and COPD: pneumonia and exacerbations?

p.245

Amiodarone + xaban: bleeding

p.245

Pralsetinib: extrapulmonary tuberculosis

p.246

Triptans: stroke and myocardial infarction

p.246

Diclofenac and other NSAIDs: allergic angina (Kounis syndrome)

p.247

Common stem: -(fl)oxacin

p.247

Outlook


Environmental impact of drugs: taking drug utilisation data into account

p.248-250

Clinical evaluation: too many endpoint changes during trials

p.251

Free  European "pharmaceutical package": letter on clinical data exclusivity

p.251

Masthead


Free  Masthead

p.226

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe